Clinical trials

  • RILVEGOSTOMIG for Non-small cell lung cancer | Advanced non-small cell lung cancer | Metastatic non-small cell lung cancer
  • TACROLIMUS MONOHYDRATE for Chronic kidney disease|Kidney transplantation
  • Tacrolimus for Liver transplantation
  • EBLASAKIMAB for Atopic dermatitis
  • NIRAPARIB TOSILATE MONOHYDRATE for Ovarian cancer (oligometastatic progression)
  • INDOCYANINE GREEN for Resectable malignant liver tumour
  • Para-chloro-2-[18F]fluoroethyl-etomidate for Primary aldosteronism
  • PEMBROLIZUMAB for Non-small cell lung cancer (NSCLC) | Squamous non-small cell lung cancer | Non-squamous non-small cell lung cancer
  • MORF-057 for Moderately to severely active Crohn's disease | Crohn's disease
  • PITOLISANT HYDROCHLORIDE for Prader-Willi syndrome
  • ipilimumab for Metastatic uveal melanoma
  • SACITUZUMAB GOVITECAN for Locally advanced/metastatic urothelial cancer